Infusions of the investigational monoclonal antibody veligrotug improved symptoms among patients with active and chronic ...

The difference in mortality rate widened in recent years between thyrotoxicosis patients with and without thyroid storm. In 2016, inhospital mortality was 2.88% and 1.82% for those with and without ...